Milestone Scientific Names Joseph D'Agostino as Acting Chief Financial Officer
January 30 2008 - 8:30AM
PR Newswire (US)
LIVINGSTON, N.J., Jan. 30 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today announced that
Joseph D'Agostino, CPA, has been appointed as the Company's new
Acting Chief Financial Officer, replacing former Acting CFO, Arthur
Goldberg. D'Agostino will serve in this role for a period of
approximately six months, and then subject to mutual consent and
Board approval at that time, he will assume the title of Chief
Financial Officer thereafter. D'Agostino brings Milestone a wealth
of finance and accounting experience earned over 25 years serving
both publicly and privately held companies. A results-oriented and
decisive leader, he has specific proven expertise in treasury and
cash management, strategic planning, information technology,
internal controls, Sarbanes-Oxley compliance, operations and
financial and tax accounting. Immediately prior to joining
Milestone, D'Agostino served as Senior Vice President and Treasurer
of Summit Global Logistics, a publicly traded, full service
international freight forwarder and customs broker with operations
in the United States and China. Previous executive posts also
included Executive Vice President and CFO of Haynes Security, Inc.,
a leading electronic and manned security solutions company serving
government agencies and commercial enterprises; Executive Vice
President of Finance and Administration for Casio, Inc., the U.S.
subsidiary of Casio Computer Co., Ltd., a leading manufacturer of
consumer electronics with subsidiaries throughout the world; and
Manager of Accounting and Auditing for Main Hurdman's (KPMG)
national office in New York City. D'Agostino is a Certified Public
Accountant and holds memberships in the American Institute of
CPA's, New Jersey Society of CPA's, Financial Executive Institute,
Consumer Electronics Industry Association and Homeland Security
Industry Association. He is a graduate of William Paterson
University where he earned a Bachelor of Arts degree in Science.
"Joseph is a highly qualified executive with an impressive skill
set and a proven track record for building financially sound
organizations with strong internal control environments. Joseph is
enthusiastic and has a passion for success. He will be an excellent
complementary addition to our team," stated Joe Martin, Milestone's
Chief Executive Officer. About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is
engaged in pioneering proprietary, highly innovative technological
solutions for the medical and dental markets. Central to the
Company's IP platform and product development strategy is its
patented CompuFlo(TM) technology for the improved and painless
delivery of local anesthetic. Specifically, CompuFlo is a
computer-controlled, pressure sensitive infusion, perfusion,
suffusion and aspiration technology, which provides real-time
readouts of pressures, fluid densities and flow rates, enabling the
advanced delivery and removal of a wide array of fluids. The Single
Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia
delivery system which uses this technology provides dentists with
audible and visual signals as to in-tissue pressure. Milestone's
existing painless injection systems are currently sold in 25
countries. For more information on these and other innovative
Milestone products, please visit the Company's web site found at
http://www.milesci.com/. Safe Harbor Statement This press release
contains forward-looking statements regarding the timing and
financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are
based on assumptions involving judgments with respect to future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond Milestone's control. Some
of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected
revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes
in customer and market requirements and standards, and the risk
factors detailed from time to time in Milestone's periodic filings
with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report on Form 10-KSB for the year
ended December 31, 2006. The forward looking-statements in this
press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or
update publicly any forward-looking statements for any reason. FOR
MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications
Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist 407-585-1080 or via email at DATASOURCE: Milestone
Scientific Inc. CONTACT: Dodi Handy, President and CEO, or Daniel
Conway, Chief Strategist of Elite Financial Communications Group,
LLC, +1-407-585-1080, , for Milestone Scientific Inc. Web site:
http://www.milesci.com/
Copyright